Vaxart (VXRT) Reports First Patient Enrollment in Phase 1b Norovirus Boosting Regimen Study

Go back to Vaxart (VXRT) Reports First Patient Enrollment in Phase 1b Norovirus Boosting Regimen Study
(NASDAQ: VXRT) Delayed: 0.32 --0 (-0%)
Previous Close $0.32    52 Week High
Open $0.32    52 Week Low
Day High $0.32    P/E N/A 
Day Low $0.32    EPS
Volume 760,302